Characterization of a recombinant monoclonal antibody by mass spectrometry combined with liquid chromatography.

In this report, we present the characterization of a humanized monoclonal antibody specific for the human epidermal growth factor receptor (hEGFR). Direct analysis by matrix assisted laser desorption ionization mass spectrometry (MALDI-MS) of peptide mixtures and chromatographically isolated fractions allowed identification of 94.0% and 85.4% of the amino acid sequence of light and heavy chains, respectively. Microheterogeneity sources were identified in light and heavy chains and a previously unreported posttranslational modification for immunoglobulins was found. One N-glycosylation site was identified in the heavy chain with non-sialylated bianntenary fucosylated structures. This study is one of the first to assess the potential of MALDI-MS in combination with more conventional protein chemistry techniques for the characterization of monoclonal antibodies.

[1]  W. Lehmann,et al.  Protease‐catalyzed incorporation of 18O into peptide fragments and its application for protein sequencing by electrospray and matrix‐assisted laser desorption/ionization mass spectrometry , 1996, Electrophoresis.

[2]  S. Akashi,et al.  Characterization of mouse switch variant antibodies by matrix-assisted laser desorption ionization mass spectrometry and electrospray ionization mass spectrometry , 1996, Journal of the American Society for Mass Spectrometry.

[3]  Hans-Werner Mewes,et al.  The PIR-International Protein Sequence Database , 1992, Nucleic Acids Res..

[4]  C. V. Smith,et al.  Identification of modified tryptophan residues in apolipoprotein B-100 derived from copper ion-oxidized low-density lipoprotein. , 1999, Biochemistry.

[5]  E. Nordhoff,et al.  Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. , 1999, Journal of mass spectrometry : JMS.

[6]  G. Gibson,et al.  Epidermal growth factor receptors in non-small cell lung cancer. , 1987, British Journal of Cancer.

[7]  I. Shimada,et al.  Complete and rapid peptide and glycopeptide mapping of mouse monoclonal antibody by LC/MS/MS using ion trap mass spectrometry. , 1998, Analytical chemistry.

[8]  H. Wenschuh,et al.  The dominance of arginine-containing peptides in MALDI-derived tryptic mass fingerprints of proteins. , 1999, Analytical chemistry.

[9]  R. Class,et al.  Epidermal growth factor receptor 425 monoclonal antibodies radiolabeled with iodine-125 in the adjuvant treatment of high-grade astrocytomas. , 1995, Hybridoma.

[10]  T. Rudel,et al.  Analysis of missed cleavage sites, tryptophan oxidation and N-terminal pyroglutamylation after in-gel tryptic digestion. , 2000, Rapid communications in mass spectrometry : RCM.

[11]  W. Zschiesche,et al.  A new monoclonal antibody for detection of EGF‐receptors in western blots and paraffin‐embedded tissue sections , 1992, Journal of cellular biochemistry.

[12]  S. Carr,et al.  An integrated strategy for structural characterization of the protein and carbohydrate components of monoclonal antibodies: application to anti-respiratory syncytial virus MAb. , 1995, Analytical chemistry.

[13]  S. Larson,et al.  Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma. , 1991, Journal of the National Cancer Institute.

[14]  Martin Kussmann,et al.  Matrix‐assisted Laser Desorption/Ionization Mass Spectrometry Sample Preparation Techniques Designed for Various Peptide and Protein Analytes , 1997 .

[15]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[16]  W. Hancock,et al.  Characterization of humanized anti-TAC, an antibody directed against the interleukin 2 receptor, using electrospray ionization mass spectrometry by direct infusion, LC/MS, and MS/MS. , 1994, Analytical chemistry.

[17]  M. Ramos-Suzarte,et al.  99mTc-labeled antihuman epidermal growth factor receptor antibody in patients with tumors of epithelial origin: Part III. Clinical trials safety and diagnostic efficacy. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  L. Taylor,et al.  Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. , 1997, Analytical biochemistry.

[19]  H. Yamaguchi,et al.  Structural characterization of mouse monoclonal antibody 13-1 against a porphyrin derivative: identification of a disulfide bond in CDR-H3 of Mab 13-1. , 1997, Biochemical and biophysical research communications.

[20]  L. Skoog,et al.  Receptors for epidermal growth factor and sex steroid hormones in human colorectal carcinomas. , 1989, Anticancer research.

[21]  C Mateo,et al.  Humanization of a mouse monoclonal antibody that blocks the epidermal growth factor receptor: recovery of antagonistic activity. , 1997, Immunotechnology : an international journal of immunological engineering.

[22]  Choh Hao Li.  Techniques in protein chemistry , 1980 .

[23]  L. Skoog,et al.  Heterogenous expression of the EGF-receptor in human breast carcinoma. , 1992, Anticancer research.

[24]  R D Appel,et al.  A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. , 1994, Trends in biochemical sciences.

[25]  N. Iznaga-Escobar,et al.  Freeze-dried formulation for direct 99mTc-labeling ior-egf/r3 MAb: additives, biodistribution, and stability. , 1999, Nuclear medicine and biology.